1 - 10 out of 15Page size: 10
  1. 2022

  2. GATA2 haploinsufficient patients lack innate lymphoid cells that arise after hematopoietic cell transplantation

    van Lier, Y. F., Krabbendam, L., Haverkate, N. J. E., Zeerleder, S. S., Rutten, C. E., Blom, B., Spits, H. & Hazenberg, M. D., 3 Oct 2022, In: Frontiers in immunology. 13, 1020590.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2021

  4. CD127+ CD94+ innate lymphoid cells expressing granulysin and perforin are expanded in patients with Crohn’s disease

    Krabbendam, L., Heesters, B. A., Kradolfer, C. M. A., Haverkate, N. J. E., Becker, M. A. J., Buskens, C. J., Bemelman, W. A., Bernink, J. H. & Spits, H., 1 Dec 2021, In: Nature communications. 12, 1, 5841.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Identification of human cytotoxic ILC3s

    Krabbendam, L., Heesters, B. A., Kradolfer, C. M. A., Spits, H. & Bernink, J. H., Apr 2021, In: European journal of immunology. 51, 4, p. 811-823 13 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Innate lymphoid cells: from helper to killer

    Krabbendam, L., Bernink, J. H. & Spits, H., 1 Feb 2021, In: Current opinion in immunology. 68, p. 28-33 6 p.

    Research output: Contribution to journal › Review article › Academic › peer-review

  7. Human innate lymphoid cells: From helper to killer

    Krabbendam, L., 2021, 239 p.

    Research output: Thesis › Phd-Thesis - Research and graduation internal

  8. 2020

  9. Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies (Nature Immunology, (2019), 20, 8, (992-1003), 10.1038/s41590-019-0423-0)

    Bernink, J. H., Ohne, Y., Teunissen, M. B. M., Wang, J., Wu, J., Krabbendam, L., Guntermann, C., Volckmann, R., Koster, J., van Tol, S., Ramirez, I., Shrestha, Y., de Rie, M. A., Spits, H., Ros, X. R. & Humbles, A. A., 1 Jan 2020, In: Nature immunology. 21, 1, p. 101 1 p.

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  10. 2019

  11. Erratum: KLRG1 and NKp46 discriminate subpopulations of human CD117+CRTH2- ILCs biased toward ILC2 or ILC3 (Journal of Experimental Medicine (2019) 216: 8 DOI: 10.1084/jem.20190490)

    Nagasawa, M., Heesters, B. A., Kradolfer, C. M. A., Krabbendam, L., Martinez-Gonzalez, I., de Bruijn, M. J. W., Golebski, K., Hendriks, R. W., Stadhouders, R., Spits, H. & Bal, S. M., 1 Sep 2019, In: Journal of experimental medicine. 216, 9, p. 2221-2222 1 p.

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  12. c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies

    Bernink, J. H., Ohne, Y., Teunissen, M. B. M., Wang, J., Wu, J., Krabbendam, L., Guntermann, C., Volckmann, R., Koster, J., van Tol, S., Ramirez, I., Shrestha, Y., de Rie, M. A., Spits, H., Romero Ros, X. & Humbles, A. A., 1 Aug 2019, In: Nature immunology. 20, 8, p. 992-1003 12 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  13. Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF-dependent mechanism

    Bánki, Z., Krabbendam, L., Klaver, D., Leng, T., Kruis, S., Mehta, H., Müllauer, B., Orth-Höller, D., Stoiber, H., Willberg, C. B. & Klenerman, P., 10 Jul 2019, In: Immunology and cell biology. 97, 6, p. 538-551

    Research output: Contribution to journal › Article › Academic › peer-review

  14. Human ectoenzyme-expressing ILC3: Immunosuppressive innate cells that are depleted in graft-versus-host disease

    Hazenberg, M. D., Haverkate, N. J. E., van Lier, Y. F., Spits, H., Krabbendam, L., Bemelman, W. A., Buskens, C. J., Blom, B. & Shikhagaie, M. M., 2019, In: Blood advances. 3, 22, p. 3650-3660

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 Next

ID: 111419